What should be the entry pain intensity criteria for chronic pain clinical trials? An IMMPACT update

被引：7
|
作者：
Langford, Dale J. [1 ,2 ,3 ]
Baron, Ralf [4 ]
Edwards, Robert R. [5 ]
Gewandter, Jennifer S. [2 ]
Gilron, Ian [6 ]
Griffin, Robert [1 ]
Kamerman, Peter R. [7 ]
Katz, Nathaniel P. [8 ]
McDermott, Michael P. [2 ]
Rice, Andrew S. C. [9 ]
Turk, Dennis C. [3 ]
Vollert, Jan [9 ]
Dworkin, Robert H. [2 ]
机构：
[1] Hosp Special Surg, Dept Anesthesiol Crit Care & Pain Management, New York, NY USA
[2] Univ Rochester, Dept Anesthesiol & Perioperat Med, Rochester, NY USA
[3] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA USA
[4] Univ Kiel, Dept Neurol, Kiel, Germany
[5] Harvard Med Sch, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA
[6] Queens Univ, Dept Anesthesiol & Perioperat Med, Kingston, ON, Canada
[7] Univ Witwatersrand, Sch Psychol, Johannesburg, South Africa
[8] Tufts Univ, Dept Anesthesiol, Boston, MA USA
[9] Imperial Coll London, Dept Surg & Canc, London, England
来源：
PAIN | 2023年 / 164卷 / 09期
关键词：
ASSAY SENSITIVITY; NEUROPATHIC PAIN; INDIVIDUAL PATIENT; METAANALYSIS; REGRESSION; FEATURES; TIME;
D O I：
10.1097/j.pain.0000000000002930
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
[No abstract available]
引用
收藏
页码：1927 / 1930
页数：4
相关论文
共 50 条
  • [1] What should be the core outcomes in chronic pain clinical trials?
    Turk, DC
    Dworkin, RH
    ARTHRITIS RESEARCH & THERAPY, 2004, 6 (04) : 151 - 154
  • [2] What should be the core outcomes in chronic pain clinical trials?
    Dennis C Turk
    Robert H Dworkin
    Arthritis Res Ther, 6
  • [3] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
    Edwards, Robert R.
    Dworkin, Robert H.
    Turk, Dennis C.
    Angst, Martin S.
    Dionne, Raymond
    Freeman, Roy
    Hansson, Per
    Haroutounian, Simon
    Arendt-Nielsen, Lars
    Attal, Nadine
    Baron, Ralf
    Brell, Joanna
    Bujanover, Shay
    Burke, Laurie B.
    Carr, Daniel
    Chappell, Amy S.
    Cowan, Penney
    Etropolski, Mila
    Fillingim, Roger B.
    Gewandter, Jennifer S.
    Katz, Nathaniel P.
    Kopecky, Ernest A.
    Markman, John D.
    Nomikos, George
    Porter, Linda
    Rappaport, Bob A.
    Rice, Andrew S. C.
    Scavone, Joseph M.
    Scholz, Joachim
    Simon, Lee S.
    Smith, Shannon M.
    Tobias, Jeffrey
    Tockarshewsky, Tina
    Veasley, Christine
    Versavel, Mark
    Wasan, Ajay D.
    Wen, Warren
    Yarnitsky, David
    PAIN, 2016, 157 (09) : 1851 - 1871
  • [4] Core outcome domains for chronic pain clinical trials: IMMPACT recommendations
    Turk, DC
    Dworkin, RH
    Allen, RR
    Bellamy, N
    Brandenburg, N
    Carr, DB
    Cleeland, C
    Dionne, R
    Farrar, JT
    Galer, BS
    Hewitt, DJ
    Jadad, AR
    Katz, NP
    Kramer, LD
    Manning, DC
    McCormick, CG
    McDermott, MP
    McGrath, P
    Quessy, S
    Rappaport, BA
    Robinson, JP
    Royal, MA
    Simon, L
    Stauffer, JW
    Stein, W
    Tollett, J
    Witter, J
    PAIN, 2003, 106 (03) : 337 - 345
  • [5] Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
    Edwards, Robert R.
    Dworkin, Robert H.
    Turk, Dennis C.
    Angst, Martin S.
    Dionne, Raymond
    Freeman, Roy
    Hansson, Per
    Haroutounian, Simon
    Arendt-Nielsen, Lars
    Attal, Nadine
    Baron, Ralf
    Brell, Joanna
    Bujanover, Shay
    Burke, Laurie B.
    Carr, Daniel
    Chappell, Amy S.
    Cowan, Penney
    Etropolski, Mila
    Fillingim, Roger B.
    Gewandter, Jennifer S.
    Katz, Nathaniel P.
    Kopecky, Ernest A.
    Markman, John D.
    Nomikos, George
    Porter, Linda
    Rappaport, Bob A.
    Rice, Andrew S. C.
    Scavone, Joseph M.
    Scholz, Joachim
    Simon, Lee S.
    Smith, Shannon M.
    Tobias, Jeffrey
    Tockarshewsky, Tina
    Veasley, Christine
    Versavel, Mark
    Wasan, Ajay D.
    Wen, Warren
    Yarnitsky, David
    PAIN REPORTS, 2021, 6 (01) : E896
  • [6] Core outcome measures for chronic pain clinical trials: IMMPACT recommendations
    Dworkin, RH
    Turk, DC
    Farrar, JT
    Haythornthwaite, JA
    Jensen, MP
    Katz, NP
    Kerns, RD
    Stucki, G
    Allen, RR
    Bellamy, N
    Carr, DB
    Chandler, J
    Cowan, P
    Dionne, R
    Galer, BS
    Hertz, S
    Jadad, AR
    Kramer, LD
    Manning, DC
    Martin, S
    McCormick, CG
    McDermott, MP
    McGrath, P
    Quessy, S
    Rappaport, BA
    Robbins, W
    Robinson, JP
    Rothman, M
    Royal, MA
    Simon, L
    Stauffer, JW
    Stein, W
    Tollett, J
    Wernicke, J
    Witter, J
    PAIN, 2005, 113 (1-2) : 9 - 19
  • [7] Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain
    Turk, Dennis C.
    Dworkin, Robert H.
    Revicki, Dennis
    Harding, Gale
    Burke, Laurie B.
    Cella, David
    Cleeland, Charles S.
    Cowan, Penney
    Farrar, John T.
    Hertz, Sharon
    Max, Mitchell B.
    Rappaport, Bob A.
    PAIN, 2008, 137 (02) : 276 - 285
  • [8] Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey
    Mazzei, Lauren Giustti
    Bergamaschi, Cristiane de Cassia
    Silva, Marcus Tolentino
    Barberato Filho, Silvio
    Fulone, Izabela
    Moura, Mariana Del Grossi
    Guimaraes, Caio
    Lopes, Luciane Cruz
    PLOS ONE, 2020, 15 (04):
  • [9] Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations
    Dworkin, Robert H.
    Turk, Dennis C.
    Wyrwich, Kathleen W.
    Beaton, Dorcas
    Cleeland, Charles S.
    Farrar, John T.
    Haythornthwaite, Jennifer A.
    Jensen, Mark P.
    Kerns, Robert D.
    Ader, Deborah N.
    Brandenburg, Nancy
    Burke, Laurie B.
    Cella, David
    Chandler, Julie
    Cowan, Penny
    Dimitrova, Rozalina
    Dionne, Raymond
    Hertz, Sharon
    Jadad, Alejandro R.
    Katz, Nathaniel P.
    Kehlet, Henrik
    Kramer, Lynn D.
    Manning, Donald C.
    McCormick, Cynthia
    McDermott, Michael P.
    McQuay, Henry J.
    Patel, Sanjay
    Porter, Linda
    Quessy, Steve
    Rappaport, Bob A.
    Rauschkolb, Christine
    Revickl, Dennis A.
    Rothman, Margaret
    Schmader, Kenneth E.
    Stacey, Brett R.
    Stauffer, Joseph W.
    Von Stein, Thorsten
    White, Richard E.
    Witter, James
    Zavislc, Stojan
    JOURNAL OF PAIN, 2008, 9 (02): : 105 - 121
  • [10] Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations
    Dworkin, Robert H.
    Turk, Dennis C.
    Peirce-Sandner, Sarah
    Burke, Laurie B.
    Farrar, John T.
    Gilron, Ian
    Jensen, Mark P.
    Katz, Nathaniel P.
    Raja, Srinivasa N.
    Rappaport, Bob A.
    Rowbotham, Michael C.
    Backonja, Misha-Miroslav
    Baron, Ralf
    Bellamy, Nicholas
    Bhagwagar, Zubin
    Costello, Ann
    Cowan, Penney
    Fang, Weikai Christopher
    Hertz, Sharon
    Jay, Gary W.
    Junor, Roderick
    Kerns, Robert D.
    Kerwin, Rosemary
    Kopecky, Ernest A.
    Lissin, Dmitri
    Malamut, Richard
    Markman, John D.
    McDermott, Michael P.
    Munera, Catherine
    Porter, Linda
    Rauschkolb, Christine
    Rice, Andrew S. C.
    Sampaio, Cristina
    Skljarevski, Vladimir
    Sommerville, Kenneth
    Stacey, Brett R.
    Steigerwald, Ilona
    Tobias, Jeffrey
    Trentacosti, Ann Marie
    Wasan, Ajay D.
    Wells, George A.
    Williams, Jim
    Witter, James
    Ziegler, Dan
    PAIN, 2012, 153 (06) : 1148 - 1158
12345